27.10
Schlusskurs vom Vortag:
$27.15
Offen:
$26.74
24-Stunden-Volumen:
166.55K
Relative Volume:
0.14
Marktkapitalisierung:
$2.08B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$67.69M
KGV:
35.19
EPS:
0.7701
Netto-Cashflow:
$184.42M
1W Leistung:
+2.84%
1M Leistung:
-3.79%
6M Leistung:
+48.14%
1J Leistung:
+17.70%
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PGNY
Progyny Inc
|
27.11 | 2.08B | 1.29B | 67.69M | 184.42M | 0.7701 |
|
UNH
Unitedhealth Group Inc
|
387.12 | 359.79B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
94.99 | 122.87B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
398.79 | 87.17B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
276.80 | 72.89B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
395.73 | 48.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know - Zacks Investment Research
Progyny (PGNY) CEO uses 5,361 shares to cover taxes - Stock Titan
Progyny (PGNY) CFO reports 479-share tax withholding - Stock Titan
Progyny at Wells Fargo healthcare conference: growth runway stays wide By Investing.com - Investing.com Canada
PGNY Maintains by Citizens -- Price Target Raised to $33.00 - GuruFocus
Citizens JMP Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $33 - Moomoo
Citizens raises Progyny stock price target on CalPERS contract win By Investing.com - Investing.com Canada
Avoiding Lag: Real-Time Signals in (PGNY) Movement - Stock Traders Daily
Progyny: Slow But Consistent Growth With A Pristine Balance Sheet (NASDAQ:PGNY) - Seeking Alpha
CFO at Progyny (PGNY) covers RSU taxes with shares - Stock Titan
Wells Fargo's healthcare conference will feature Progyny's finance chief Sept. 8 - Stock Titan
Progyny stock price target maintained at $31 by Citizens on new offering - Investing.com UK
Progyny (PGNY) legal chief covers RSU taxes with shares - Stock Titan
Progyny stock steadies after soft Q2 guidance and revenue growth - AD HOC NEWS
Wells Fargo Conceives a High Rating for the Fertility-Benefits Biz - Yahoo Finance
Progyny (NASDAQ:PGNY) Healthcare Innovation Gains Attention - Kalkine Media
PGNY Maintained by JP Morgan -- Price Target Raised to $30.00 - GuruFocus
JPMorgan Chase & Co. Boosts Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
Progyny (NASDAQ:PGNY) Upgraded at Wells Fargo & Company - MarketBeat
Tocqueville Asset Management L.P. Takes Position in Progyny, Inc. $PGNY - MarketBeat
Danske Bank A S Purchases Shares of 528,717 Progyny, Inc. $PGNY - MarketBeat
PGNY Initiated Coverage by Wells Fargo -- Rating Overweight Anno - GuruFocus
Progyny (PGNY) Q2 2026 Earnings Call Transcript - AOL.com
Wells Fargo Initiates Progyny at Overweight With $37 Price Target - marketscreener.com
Wells Fargo Initiates Progyny(PGNY.US) With Buy Rating, Announces Target Price $37 - Moomoo
Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentals - ChartMill
Bank of America Corp DE Grows Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny (PGNY) Session Brief: Gains 1.76% to Reach $25.77 at the Close; Chart Reference: the Current Price Sits Inside the Supplied Technical Range in the Current UpdateMoving Average Ribbon - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
Discipline and Rules-Based Execution in PGNY Response - Stock Traders Daily
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook - marketbeat.com
Royal Bank of Canada Has $3.71 Million Stock Position in Progyny, Inc. $PGNY - MarketBeat
The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call - Yahoo Finance
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $36 - moomoo.com
PGNY Maintains Buy Rating -- Price Target Raised to $36.00 by Tr - GuruFocus
Truist raises Progyny price target to $36 after strong Q2 results and growing institutional support - Pluang
Truist Adjusts Price Target on Progyny to $36 From $33, Maintains Buy Rating - Moomoo
Progyny, Inc. (PGNY) Stock Forecasts - Yahoo Finance
PGNY Maintains Rating by Barclays -- Price Target Lowered to $30 - GuruFocus
Sei Investments Co. Decreases Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Progyny Drops 5.4% Amid Sector-Wide Selling - AlphaStreet
Progyny, Inc. $PGNY Shares Sold by Janus Henderson Group PLC - MarketBeat
Progyny, Inc. (PGNY) Stock Analysis: Examining The 21% Potential Upside - DirectorsTalk Interviews
Why Progyny (PGNY) Shares Are Sliding Today - finance.yahoo.com
Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up - Yahoo Finance
Quantinno Capital Management LP Grows Position in Progyny, Inc. $PGNY - MarketBeat
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND) - The Globe and Mail
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35 - Moomoo
Progyny (PGNY) Stock Sinks As Guidance Jitters Clash With Margin Strength - simplywall.st
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):